CSIMarket
 
Painreform Ltd  (NASDAQ: PRFX)
 

News about Painreform Ltd




PainReforms Bold Leap: Merging Pharmaceuticals with AI-Powered Solar Analytics
Mar 05 2025
In a groundbreaking move that sets the stage for expansive growth, PainReform Ltd (NASDAQ: PRFX) has announced its strategic acquisition of DeepSolar,...

PainReform Partners with DeepSolar: A Unique Cross-Industry Opportunity in Renewable Energy Expansion,
Feb 18 2025
DeepSolar s Strategic Leap: Merging Solar Analytics with AI and PharmaceuticalsIn a remarkable intersection of technological innovation and renewable...

Turning the Tide Will PainReform?s PRF-110 Redefine Post-Surgical Pain Management Amid Financial Struggles,
Dec 27 2024
In the realm of pharmaceutical innovation, PainReform Ltd. stands out as a clinical-stage specialty pharmaceutical company dedicated to reformulating ...

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
Nov 20 2024
PainReform Reveals Promising Topline Data for PRF-110 in Phase 3 Clinical Trial Tel Aviv, Israel PainReform Ltd. (Nasdaq: PRFX), a clinical-stage ...

PainReform Ltd Faces Continued Nasdaq Compliance Struggles Amid Ongoing Financial Challenges
Nov 07 2024
An Ongoing Battle for Compliance: PainReform Ltd?s Struggles on the Nasdaq ExchangeAs of November 7, 2024, PainReform Ltd. (NASDAQ: PRFX), a clinical-...

PainReform?s PRF-110 A Game-Changer in Post-Surgical Pain ManagementSafety and Efficacy Confirmed!,
Sep 11 2024
Navigating Post-Surgical Pain Management Post-surgical pain management is a critical component of patient care, directly influencing recovery and ove...

Navigating Pain Management in Bunionectomy Insights from the PainReform Study on PRF-110 Delivery
Aug 21 2024
: The PainReform Bunionectomy Study offers significant insights into the management of post-operative pain through a novel delivery method of PRF-110....

Advancing Pain Management PainReforms PRF-110 Shows Promise in Phase 3 Bunionectomy Study
Aug 20 2024
The pursuit of effective pain management solutions has led to innovative developments in the pharmaceutical landscape. PainReform Ltd., a clinical-sta...

Triumph Over Pain PainReforms Breakthrough in Postoperative Recovery Solutions,
Aug 12 2024
PainReform, an innovative leader in drug delivery solutions, has recently announced a significant milestone in the development and successful manufact...

Emerging Safety Data of PRF-110 Shows Significant Potential for Broader Surgical Applications,
Aug 07 2024
Emerging Safety Data Show PRF-110?s Potential for Expanded Surgical Applications TEL AVIV, Israel, Aug. 07, 2024 PainReform Ltd. (Nasdaq: PRFX), a...









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com